JESUS PAULA CARVALHO
Projetos de Pesquisa
Unidades Organizacionais
Departamento de Obstetrícia e Ginecologia, Faculdade de Medicina - Docente
LIM/58 - Laboratório de Ginecologia Estrutural e Molecular, Hospital das Clínicas, Faculdade de Medicina
LIM/58 - Laboratório de Ginecologia Estrutural e Molecular, Hospital das Clínicas, Faculdade de Medicina
111 resultados
Resultados de Busca
Agora exibindo 1 - 10 de 111
conferenceObject Neoadjuvant chemotherapy with six cycles of carboplatin and paclitaxel in advanced ovarian cancer patients not candidates for optimal primary surgery: Safety and effectivenes(2013) MIRANDA, Vanessa Costa; FEDE, Angelo Bezerra de Sousa; ANJOS, Carlos Henrique Dos; SILVA, Juliana Ribeiro da; SANCHEZ, Fernando Barbosa; BESSA, Lyvia Rodrigues da Silva; CARVALHO, Jesus Paula; ABDO FILHO, Elias; FREITAS, Daniela; BARROS, Laryssa Almeida Borges de; SILVA, Samantha Cabral Severino da; ESTEVEZ-DIZ, Maria Del PilarconferenceObject RETROSPECTIVE ANALYSIS OF RADICAL HYSTERECTOMY IN A SINGLE BRAZILIAN CANCER CENTER(2016) CARVALHO, J. P. Mancusi de; GENTA, M. L. Nogueira Dias; SADALLA, J. C.; NOBREGA, F. de Souza; ORTOLAN, N. Macerox; CARVALHO, J. Paula- Everolimus plus anastrozole for female adnexal tumor of probable Wolffian origin (FATWO) with STK11 mutation(2021) ESTEVEZ-DIZ, Maria De Pilar; BONADIO, Renata Colombo; CARVALHO, Filomena Marino; CARVALHO, Jesus PaulaFemale adnexal tumor of probable Wolffian origin (FATWO) are a rare type of cancer that originates from Wolffian duct remnants. Due to its rarity, no standard systemic treatment is established for cases of recurrent or metastatic disease. Previous literature reported the use of platinum-based chemotherapy and c-Kit tyrosine kinase inhibitors for FATWO cases with c-Kit positive expression. Currently, however, the broader availability of next-generation sequencing (NGS) tests allows a better molecular characterization of rare cancer such as FATWO and a possibility for the use of personalized, targeted therapy. Previous case series that performed NGS for FATWO patients described the presence of STK11 mutations in a considerable number of cases, representing a potential target in this population. To our knowledge, we describe here the first case report of a patient with FATWO and STK11 mutation exhibiting a considerable and durable response after treatment with an mTOR inhibitor plus endocrine therapy.
- Perioperative management in gynecological surgery based on the ERAS program(2022) SANTIAGO, Aline Evangelista; SILVA FILHO, Agnaldo Lopes da; CANDIDO, Eduardo Batista; RIBEIRO, Paulo Ayrosa; SILVA, Julio Cesar Rosa e; PRIMO, Walquiria Quida Salles Pereira; CARVALHO, Jesus Paula; PODGAEC, Sergio; LINO, Carlos Augusto Pires Costa; QUINTAIROS, Ricardo de Almeida; BRITO, Luiz Gustavo Oliveira
- The fallopian tube origin of an ovarian carcinoma(2023) CARVALHO, Jesus Paula; SUAREZ, Giovanni Miglino
bookPart Câncer de ovário: tumores epiteliais(2016) CARVALHO, Jesus Paula; SIMõES, Ricardo dos Santos; BARACAT, Edmund Chada- PREOPERATIVE EVALUATION OF ADNEXAL MASS IN BREAST CANCER PATIENTS(2021) ENNES, A.; WAGNER, M.; MAYERHOFF, E.; ANTON, C.; LEITE, L.; TESTA, L.; CARVALHO, J.
conferenceObject In Bag Morcellation: details and logistics of the technique(2016) FERNANDES, R.; ARAUJO, M.; SILVA, A. Silva e; CARVALHO, P. Mancusi de; ANTON, C.; GENTA, M. L. Nogueira Dias; RIBEIRO JR., A. Dias; SAMPAIO, D.; MIGLINO, G.; SADALLA, J. C.; CARVALHO, J. PaulaconferenceObject Cervical cancer immunomodulation through stat3 and p65 NF kappa b: Effects beyond the tumor microenvironment.(2020) ROSSETTI, Renata Ariza Marques; RODRIGUEZ, Gretel Rodriguez; SILVA JR., Ildelfonso Alves Da; CARVALHO, Jesus De Paula; ROSA, Maria Beatriz Sartor De Faria; VILLA, Luisa Lina; LEPIQUE, Ana Paula- TEN YEARS OF ICESP - PROFILE OF ENDOMETRIAL CANCER TREATMENT(2019) ANTON, C.; MAYERHOFF, E.; KLEINE, R. T.; CARVALHO, J. P.